We found that Tlr2 retinal expression increased during OIR which was suppressed by BoNT/A treatment (Fig. 4G), implying potential involvement of TLR2 in the protective effects of BoNT/A in retinopathies. This evidence concerns the gene TLR2 and retinal disorder.